WASHINGTON, DC, October 15, 2026 /24-7PressRelease/ — ADAP Advocacy today, as part of its 340B Project, released a new infographic about the 340B Drug Pricing Program. The infographic reinforces the central message of the policy paper and commercial, both released earlier this year under the same name: “340B PROGRAM: The Glue That Should Hold Our Healthcare System Together.”
Congress created the 340B Drug Pricing Program to extend federal resources and improve patient care. The Affordable Care Act added requirements for hospitals to provide free care and financial aid to poor patients, also known as charity care. What’s particularly striking is that charity care continues to decline year after year. 340B Drug purchases rose above $100 billion in 2025 across over 42,000 covered entities and over 32,000 pharmacies.
The infographic connects the dots on the program’s unfettered growth and how that growth is failing to deliver on the program’s progress. The infographic continues ADAP Advocacy’s ‘340B Too Big To Fail‘ national advocacy campaign, highlighting hospitals’ declining charity, rising healthcare executive compensation, and exploding patient medical debt, among other issues.
The infographic can be downloaded online here: https://tinyurl.com/y6asjaw2.
To learn more about ADAP Advocacy, the 340B Drug Pricing Program, or the new 340B infographic, please email [email protected].
The ADAP Advocacy mission is to promote and enhance the AIDS Drug Assistance Programs (ADAPs) and improve access to care for persons living with HIV/AIDS. ADAP Advocacy works with advocates, community, health care, government, patients, pharmaceutical companies and other stakeholders to raise awareness, offer patient educational programs, and foster greater community collaboration.
—
For the original version of this press release, please visit 24-7PressRelease.com here
Legal Disclaimer: The content on this page is syndicated from independent third-party providers. Kyrion Media makes no warranties or representations regarding the accuracy, completeness, legality, or reliability of the information, including text, images, videos, or licenses. If you are affiliated with this content or have any complaints, copyright concerns, or requests for removal, please contact us at [email protected] with the specific URL of the content in question. We will review and address valid requests promptly.
